Supported by a $953,958 grant from the Defense Advanced Research Projects Agency (DARPA), researchers at the University of California San Diego will develop a sophisticated new biosensor that can protect the nation’s water supplies from a wide range of toxins, including heavy metals and other poisons.
The 2015 edition of the U.S. News & World Report’s Best Graduate Schools guidebook, released today, highly ranks the University of California, San Diego’s professional schools in engineering and medicine, as well as its academic Ph.D. programs in the sciences.
Identify a real-world problem. Engineer a solution. And, if the solution works, figure out how it can be commercially viable. That’s what Michael Benchimol said he learned over 7 years of working in the laboratory of Sadik Esener, a professor in the departments of NanoEngineering and Electrical and Computer Engineering at the University of California, San Diego. In Benchimol’s (Ph.D., Electrical Engineering, ’12) case, it specifically means building a company to advance a targeted drug delivery platform that could make chemotherapy more effective and less toxic to the healthy tissue in the body.
Innovation is now the driving force of the global economy and the intellectual property (IP) which results drives wealth creation in companies, economic sectors, and countries. So what can universities and other public institutions do to turn innovations into IP and to protect that IP so that it generates future jobs for the U.S. economy?
Researchers at the University of California, San Diego School of Medicine have discovered that FDA-approved anti-psychotic drugs possess tumor-killing activity against the most aggressive form of primary brain cancer, glioblastoma.
In the first study of its type, researchers at the University of California, San Diego School of Medicine have looked at the health threat to pregnant women with a history of Kawasaki disease (KD), concluding that the risks are low with informed management and care.
Keep up with all the latest from UC San Diego. Subscribe to the newsletter today.
